4//SEC Filing
Yamada Tadataka 4
Accession 0001209191-21-036916
CIK 0001620463other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 6:13 PM ET
Size
5.5 KB
Accession
0001209191-21-036916
Insider Transaction Report
Form 4
Yamada Tadataka
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-28+13,871→ 13,871 totalExercise: $19.94Exp: 2031-05-27→ Common Stock (13,871 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 28, 2022, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 28, 2021.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001402530
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 6:13 PM ET
- Size
- 5.5 KB